Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma

标题
Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma
作者
关键词
Endometrial cancer, PI3K inhibitors
出版物
GYNECOLOGIC ONCOLOGY
Volume 136, Issue 2, Pages 246-253
出版商
Elsevier BV
发表日期
2014-12-19
DOI
10.1016/j.ygyno.2014.12.019

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started